Nanoform Finland OYJ Logo

Nanoform Finland OYJ

Offers nanoparticle engineering services to enhance drug performance for pharma clients.

NANOFH | ST

Overview

Corporate Details

ISIN(s):
FI4000330972
LEI:
743700JJO2NU8LBS1592
Country:
Finland
Address:
Viikinkaari 4, FI-00790 HELSINKI

Description

Nanoform is a nanoparticle medicine enabling company that provides expert services in drug particle engineering to the global pharmaceutical and biotech industries. The company utilizes its proprietary, scalable Controlled Expansion of Supercritical Solutions (CESS®) technology to enhance the performance of both small and large molecule therapeutics. By creating uniform nanoparticles, Nanoform's services aim to improve drug bioavailability and solubility, enable higher drug loading in smaller dosage forms, and facilitate novel delivery routes such as subcutaneous, long-acting injectable, and inhaled formulations. The company partners with clients throughout the drug development lifecycle to overcome formulation challenges and reduce clinical trial attrition.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Nanoform Finland OYJ filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nanoform Finland OYJ

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Nanoform Finland OYJ via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

GlaxoSmithKline PLC Logo
A global biopharma company developing medicines and vaccines to prevent and treat disease.
United Kingdom
GSK
GL Pharm Tech Corp. Logo
Develops incrementally modified drugs using advanced drug delivery technologies.
South Korea
204840
GNI  Group Ltd. Logo
Multinational biopharma firm developing drugs, TCMs, and medical devices.
Japan
2160
Goodwill Pharma Plc Logo
Develops, manufactures, and distributes medicines, supplements, and medical devices.
Hungary
GWPH
Gossamer Bio, Inc. Logo
Clinical-stage biopharma developing an inhaled therapy for pulmonary hypertension.
United States of America
GOSS
Grace Therapeutics, Inc. Logo
Late-stage biopharma developing drugs for rare and orphan neurological conditions.
United States of America
GRCE
Green Cross Corporation Logo
Develops protein therapeutics, vaccines, diagnostics, and consumer health products.
South Korea
006280
A holding company in biopharma, diagnostics, consumer, and digital healthcare.
South Korea
005250
GREEN CROSS WellBeing Corporation Logo
Develops nutritional injections, health supplements, and cosmetics.
South Korea
234690
Greenwich LifeSciences, Inc. Logo
A clinical-stage biopharma developing immunotherapies to prevent cancer recurrence.
United States of America
GLSI

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.